LEAP2: Next game-changer of pharmacotherapy for overweight and obesity?

The world is seeking effective and safe weight-lowering drugs for centuries. LEAP2, acting on ghrelin and growth hormone secretagogue receptor, according to a study by Hageman et al.(1) in this issue of Cell Reports Medicine, found its way toward the next target of pharmacotherapy for obesity and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dan, Li, Sheyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Preview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044093/
https://www.ncbi.nlm.nih.gov/pubmed/35492250
http://dx.doi.org/10.1016/j.xcrm.2022.100612
_version_ 1784695031325523968
author Liu, Dan
Li, Sheyu
author_facet Liu, Dan
Li, Sheyu
author_sort Liu, Dan
collection PubMed
description The world is seeking effective and safe weight-lowering drugs for centuries. LEAP2, acting on ghrelin and growth hormone secretagogue receptor, according to a study by Hageman et al.(1) in this issue of Cell Reports Medicine, found its way toward the next target of pharmacotherapy for obesity and related diseases.
format Online
Article
Text
id pubmed-9044093
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90440932022-04-28 LEAP2: Next game-changer of pharmacotherapy for overweight and obesity? Liu, Dan Li, Sheyu Cell Rep Med Preview The world is seeking effective and safe weight-lowering drugs for centuries. LEAP2, acting on ghrelin and growth hormone secretagogue receptor, according to a study by Hageman et al.(1) in this issue of Cell Reports Medicine, found its way toward the next target of pharmacotherapy for obesity and related diseases. Elsevier 2022-04-19 /pmc/articles/PMC9044093/ /pubmed/35492250 http://dx.doi.org/10.1016/j.xcrm.2022.100612 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Preview
Liu, Dan
Li, Sheyu
LEAP2: Next game-changer of pharmacotherapy for overweight and obesity?
title LEAP2: Next game-changer of pharmacotherapy for overweight and obesity?
title_full LEAP2: Next game-changer of pharmacotherapy for overweight and obesity?
title_fullStr LEAP2: Next game-changer of pharmacotherapy for overweight and obesity?
title_full_unstemmed LEAP2: Next game-changer of pharmacotherapy for overweight and obesity?
title_short LEAP2: Next game-changer of pharmacotherapy for overweight and obesity?
title_sort leap2: next game-changer of pharmacotherapy for overweight and obesity?
topic Preview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044093/
https://www.ncbi.nlm.nih.gov/pubmed/35492250
http://dx.doi.org/10.1016/j.xcrm.2022.100612
work_keys_str_mv AT liudan leap2nextgamechangerofpharmacotherapyforoverweightandobesity
AT lisheyu leap2nextgamechangerofpharmacotherapyforoverweightandobesity

Ejemplares similares